[1]
International Diabetes Federation: In: IDF Diabetes Atlas. Brussels, Belgium 2013.
[2]
Hwang LC, Bai CH, Sun CA, et al. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012; 21(2): 227-33.
[3]
Van Gaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care 2015; 38(6): 1161-72.
[4]
Gill RS, Sharma AM, Al-Adra DP, et al. The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev 2011; 7(3): 185-9.
[5]
Melissas J, Stavroulakis K, Tzikoulis V, et al. Sleeve gastrectomy vs. roux-en-y gastric bypass. Data from IFSO-European Chapter center of excellence program. Obes Surg 2017; 27(4): 847-55.
[6]
Kular KS, Manchanda N, Cheema GK. Seven years of mini-Gastric bypass in type ii diabetes patients with a body mass index <35 kg/m. Obes Surg 2016; 26(7): 1457-62.
[7]
Svane MS, Madsbad S. Bariatric surgery - effects on obesity and related co-morbidities. Curr Diabetes Rev 2014; 10(3): 208-14.
[8]
Kalyvas AV, Vlachos K, Abu-Amara M, et al. Bariatric surgery as metabolic surgery for diabetic patients. Curr Pharm Des 2014; 20(22): 3631-46.
[9]
] Abed O, Kabir A, Jesmi F, et al. Laparoscopic roux-en-y versus one anastomosis gastric bypass on remission of diabetes in morbid obesity. J Minim Invasive Surg Sci . 2017. e55991
[10]
Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol 2014; 20(41): 15135-43.
[11]
Chang S, Stoll CT, Song J, et al. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014; 149(3): 275-87.
[12]
Keidar A. Bariatric surgery for type 2 diabetes reversal: The risks. Diabetes Care 2011; 34(Suppl. 2): S361-266.
[13]
Lee WJ, Almulaifi A, Chong K, et al. Bariatric versus diabetes surgery after five years of follow up. Asian J Surg 2016; 39(2): 96-102.
[14]
Zorzela L, Loke YK, Ioannidis JP, et al. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ 2016; 352: i157.
[15]
Boza C, Munoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg 2011; 21(9): 1330-6.
[16]
Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs. banding: Results of a 2-cohort pair-matched study. Arch Surg 2011; 146(2): 149-55.
[17]
Blackstone R, Kieran J, Davis M, et al. Continuous perioperative insulin infusion therapy for patients with type 2 diabetes undergoing bariatric surgery. Surg Endosc 2007; 21(8): 1316-22.
[18]
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311(22): 2297-304.
[19]
Savovic J, Weeks L, Sterne JA, et al. Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev 2014; 3: 37.
[20]
Wells G, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale(NOS) for assessing the quality of nonrandomised studies in metaanalyses, 2000.
[21]
Sarwar H, Chapman WH 3rd, Pender JR, et al. Hypoglycemia after Roux-en-Y gastric bypass: The BOLD experience. Obes Surg 2014; 24(7): 1120-4.
[22]
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366(17): 1567-76.
[23]
Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surgery for obesity and related diseases : Official journal of the American Society for Bariatric Surgery . 2008; 4(4): 492-9.
[24]
Marsk R, Jonas E, Rasmussen F, et al. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 2010; 53(11): 2307-11.
[25]
Inabnet WB 3rd, Winegar DA, Sherif B, et al. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg 2012; 214(4): 550-6.
[26]
Gupta PK, Franck C, Miller WJ, et al. Development and validation of a bariatric surgery morbidity risk calculator using the prospective, multicenter NSQIP dataset. J Am Coll Surg 2011; 212(3): 301-9.
[27]
Kim JH, Wolfe B. Bariatric/metabolic surgery: short- and longterm safety. Curr Atheroscler Rep 2012; 14(6): 597-605.
[28]
Chuah LL, Papamargaritis D, Pillai D, et al. Morbidity and mortality of diabetes with surgery. Nutr Hosp 2013; 28(Suppl. 2): 47-52.
[29]
Bradley JF 3rd, Ross SW, Christmas AB, et al. Complications of bariatric surgery: The acute care surgeon’s experience. Am J Surg 2015; 210(3): 456-61.
[30]
Weiner RA, El-Sayes IA, Theodoridou S, et al. Early postoperative complications: Incidence, management, and impact on length of hospital stay. A retrospective comparison between laparoscopic gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23(12): 2004-12.
[31]
Nguyen NT, Masoomi H, Laugenour K, et al. Predictive factors of mortality in bariatric surgery: Data from the Nationwide Inpatient Sample. Surgery 2011; 150(2): 347-51.
[32]
Dorman RB, Miller CJ, Leslie DB, et al. Risk for hospital readmission following bariatric surgery. PLoS One 2012; 7(3): e32506.
[33]
Halperin F, Goldfine AB. Metabolic surgery for type 2 diabetes: efficacy and risks. Curr Opin Endocrinol Diabetes Obes 2013; 20(2): 98-105.
[34]
Chivot C, Robert B, Lafaye N, et al. Laparoscopic sleeve gastrectomy: Imaging of normal anatomic features and postoperative gastrointestinal complications. Diagn Interv Imaging 2013; 94(9): 823-34.
[35]
Corcelles R, Daigle CR, Schauer PR. Management Of Endocrine Disease: Metabolic effects of bariatric surgery. European journal of endocrinology / European Federation of Endocrine Societies 2016; 174(1): R19-28.
[36]
Golder S, Loke YK. Reporting of adverse events in published and unpublished studies of health care interventions: A systematic review. PLoS Med 2016; 13(9): e1002127.
[37]
Kaska L, Proczko M, Kobiela J, et al. Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m(2) and higher than 35 kg/m(2) in a 3-year observation period. Wideochir Inne Tech Malo Inwazyjne 2014; 9(4): 523-30.
47
7
1